Advertisement
News
Subscribe to MDT Magazine News

Type 2 Diabetes Patients Achieve Greater Satisfaction with Insulin Pumps vs. Multiple Daily Injections

September 16, 2014 9:44 am | by Medtronic | Comments

Medtronic, Inc. today announced that new results from the OpT2mise trial are being presented at the European Association for the Study of Diabetes (EASD) 50th Annual Meeting. OpT2mise is the largest global study to compare insulin pump therapy...

TOPICS:

The Shadow of a Disease

September 16, 2014 9:37 am | by Max Planck Gesellschaft | Comments

In the future, some diseases might be diagnosed earlier and treated more effectively. Researchers at the Max Planck Institute for the Science of Light in Erlangen have developed an optical method that makes individual proteins', such as the proteins...

TOPICS:

Blood Test Could Help Determine Treatment Options for Esophageal Cancer Patients

September 16, 2014 9:30 am | by American Society for Radiation Oncology | Comments

A blood test may be beneficial in indicating neoadjuvant treatment regimens for patients with esophageal squamous cell carcinoma (ESCC), according to research presented today at the American Society for Radiation Oncology's (ASTRO's) 56th...

TOPICS:
Advertisement

Researchers Develop Improved Means of Detecting Mismatched DNA

September 16, 2014 9:20 am | by Johns Hopkins Medicine | Comments

Researchers at Johns Hopkins have identified a highly sensitive means of analyzing very tiny amounts of DNA. The discovery, they say, could increase the ability of forensic scientists to match genetic material in some criminal investigations...

TOPICS:

New York State a Beacon for Bio/Med Growth

September 16, 2014 9:13 am | by Jamie Leszczynski | Comments

The Bio/Med Breakthroughs: Advancing New York’s Innovation Economy industry report by MedTech, the trade association for bioscience and medical technology (Bio/Med) companies in New York, which was launched today at MEDTECH 2014, reveals a...

TOPICS:

Flowonix Submits PMA Supplements for Prometra Implantable Pump System

September 16, 2014 8:58 am | by Flowonix | Comments

Flowonix Medical Inc., a medical device company focused on providing advanced, implantable drug delivery solutions, today announced that it has submitted Premarket Approval (PMA) supplements to the U.S. Food and Drug Administration (FDA)...

TOPICS:

Predicting Prostate Cancer: Pitt-Developed Test Identifies New Methods for Treatment

September 15, 2014 2:08 pm | by University of Pittsburgh Schools of the Health Sciences | Comments

A genetic discovery out of the University of Pittsburgh School of Medicine is leading to a highly accurate test for aggressive prostate cancer and identifies new avenues for treatment. The analysis, published today in the American Journal of...

TOPICS:

Blood-Cleansing Biospleen Device Developed for Sepsis Therapy

September 15, 2014 12:12 pm | by Wyss Institute for Biologically Inspired Engineering at Harvard | Comments

Things can go downhill fast when a patient has sepsis, a life-threatening condition in which bacteria or fungi multiply in a patient's blood – often too fast for antibiotics to help. A new device inspired by the human spleen and developed by...

TOPICS:
Advertisement

Genetic Testing Can Identify Men at Six-Fold Increased Risk of Prostate Cancer

September 15, 2014 11:58 am | by Institute of Cancer Research | Comments

Scientists can now explain a third of the inherited risk of prostate cancer, after a major international study identified 23 new genetic variants associated with increased risk of the disease. The study brings the total number of common genetic...

TOPICS:

Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent

September 15, 2014 10:49 am | by PR Newswire | Comments

Abbott announced today positive one-year clinical results from ABSORB II, the world's first prospective, randomized, controlled trial comparing the safety and effectiveness of the dissolving Absorb heart device to Abbott's market-leading metallic...

TOPICS:

Medtronic Launches SEEQ Wearable Cardiac Monitoring System in United States

September 15, 2014 10:18 am | by Medtronic | Comments

Medtronic, Inc. has announced the U.S. launch of the SEEQ Mobile Cardiac Telemetry (MCT) System, an external, wire-free, adhesive heart monitor that can be worn for up to 30 days to help detect and diagnose the cause of irregular heartbeats in...

TOPICS:

Medtronic’s CoreValve System Sustains Positive Outcomes Through Two Years in Extreme Risk Patients

September 15, 2014 10:14 am | by Medtronic | Comments

Medtronic, Inc. has announced new data showing that transcatheter aortic valve replacement (TAVR) with the CoreValve System continued to provide safe and effective treatment, while maintaining exceptional rates of survival out to two years for...

TOPICS:

Toughening Up Hydrogels for 3D-Printed Cartilage

September 15, 2014 10:11 am | by University of Wollongong | Comments

Thanks to their composition (mostly water), hydrogels hold much promise for use in medical bionic applications, their softness being more readily acceptable to the body than hard materials. However, despite naturally occurring hydrogels (like...

TOPICS:

Researchers Take Up Challenge of Reviving Cartilage

September 15, 2014 10:03 am | by Stanford | Comments

Constance Chu was a medical student observing a surgery performed by her teacher when she caught her first glimpse of human articular cartilage, the smooth, glistening coating that covers the ends of bones as they meet at the ankle, knee and...

TOPICS:

Quantel Medical's Vitra PDT Laser Receives CE Mark Approval

September 15, 2014 9:48 am | by PR Newswire | Comments

Quantel Medical today announced CE Mark approval for its Vitra PDT photodynamic therapy laser platform, for the treatment of polypoidal choroidal vasculopathy (PCV) and central serous retinopathy (CSR). Quantel, the sole manufacturer of this...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading